MDR
Showing 1 - 25 of 740
Perinatal Transmission of MDR Bacteria
Recruiting
- E. Coli Infection
- Multi-antibiotic Resistance
-
Chicago, IllinoisPrentice Women's Hospital
Nov 20, 2023
MDR-TB, Immunotherapy Trial in Shanghai (V?2Vd2 T lymphocyte-based immunotherapy, Treatment regimens for MDR-TB)
Recruiting
- MDR-TB
- Immunotherapy
- Vγ2Vδ2 T lymphocyte-based immunotherapy
- Treatment regimens for MDR-TB
-
Shanghai, China
- +1 more
Aug 8, 2022
Household Transmission Dynamics of Multidrug Resistant
Not yet recruiting
- Adults Patients, With Fecal Carriage of Multi-Drug Resistant Enterobacterales (MDR-E)
- (no location specified)
Apr 3, 2023
MDR-TB Trial in Shanghai (PRS Regimen V, MDR-TB Treatment Regimen(WHO))
Recruiting
- MDR-TB
- PRS Regimen V
- MDR-TB Treatment Regimen(WHO)
-
Shanghai, ChinaShanghai Pulmonary Hospital
Aug 4, 2022
AMR-DetecTool for the Diagnostic of MDR Bacterial Infections
Completed
- Bacterial Sensitivity Tests
- Antimicrobial Drug Resistance
- AMR LFIA Assay
-
Le Kremlin-Bicêtre, France
- +2 more
Jan 12, 2023
ICU-acquired Colonization and Infection Related to MDR in
Completed
- Immunocompromised Host
- Critical Care
-
Amiens, France
- +6 more
Oct 4, 2022
Plasmid Inhibitors and Antimicrobial Drugs Against Clinical
Not yet recruiting
- Synergy Between Plasmid Inhibitors and Combined Antibiotics
- (no location specified)
Jun 27, 2023
MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)
Active, not recruiting
- MDR-TB
- Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
- +9 more
-
Addis Ababa, Ethiopia
- +12 more
Oct 12, 2022
Pre-XDR-TB Trial in Seoul (BPaL regimen)
Not yet recruiting
- Pre-XDR-TB
- BPaL regimen
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Jul 19, 2022
Instant Cardiac Diagnostic and Post-operative Risk Assessment
Not yet recruiting
- Cardiovascular Diseases
- Heart Diseases
- LynxPatch
- (no location specified)
Aug 4, 2023
Kidney Transplant Rejection Trial (MDR-103)
Not yet recruiting
- Kidney Transplant Rejection
- MDR-103
- (no location specified)
Apr 4, 2022
Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)
Not yet recruiting
- Kidney Transplant Rejection
- MDR-102
- Immunosuppressive Agents
- (no location specified)
Apr 4, 2022
Tuberculosis, Multidrug Resistant Trial in Chernivtsi, Ivano-Frankivs'k, Kharkiv (RUTI® Therapeutic vaccine, Matching RUTI®
Terminated
- Tuberculosis, Multidrug Resistant
- RUTI® Therapeutic vaccine
- Matching RUTI® Placebo
-
Chernivtsi, Ukraine
- +2 more
Jun 30, 2022
MDR ExploR Radial Head System PMCF
Enrolling by invitation
- Elbow Injury
- ExploR Radial Head
-
Louisville, KentuckyNorton Healthcare
Oct 13, 2022
Factors Impacting the Prevalence of MDR Bacteria
Completed
- Multi-antibiotic Resistance
-
Najaf, IraqFaculty of pharmacy /kufa university
Aug 17, 2022
Stress Disorders, Post-Traumatic Trial run by the (Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation
Recruiting
- Stress Disorders, Post-Traumatic
- Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR)
-
Bethesda, MarylandUniformed Services University
Feb 14, 2022
Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)
Recruiting
- Tuberculosis, Multidrug-Resistant
- Delamanid
- +4 more
-
Dasmariñas, Philippines
- +1 more
Jun 21, 2022
Bone Resistant Tuberculosis
Completed
- Bone and Osteoarticular Infection Due to MDR M. Tuberculosis Strains
- Descriptive retrospective study
-
Paris, FrancePitié Salpêtrière Hospital
May 9, 2022
Hypertension Trial in Ankara (Genetic analysis and Losartan plazma level measurement)
Completed
- Hypertension
- Genetic analysis and Losartan plazma level measurement
-
Ankara, TurkeyGazi University
Apr 22, 2022
MDR - Longevity IT Oblique and Offset Liners
Not yet recruiting
- Non-inflammatory Degenerative Joint Disease (NIDJD)
- +8 more
- Total Hip Arthroplasty with Longevity IT Oblique Liners
- Total Hip Arthroplasty with Longevity IT Offset Liners
- (no location specified)
Aug 4, 2023
Multi-drug Resistant Tuberculosis Trial in China (18-month regimen containing 6 anti-TB drugs)
Completed
- Multi-drug Resistant Tuberculosis
- 18-month regimen containing 6 anti-TB drugs
-
Beijing, China
- +19 more
Oct 10, 2022
MDR - G7 Neutral and G7 Freedom Constrained Neutral Acetabular
Withdrawn
- Hip Osteoarthritis
- +3 more
- G7 Freedom Constrained Liners
- (no location specified)
Jul 20, 2022
MDR-TB, HIV Trial in South Africa (NCM-Plus)
Active, not recruiting
- MDR-TB
- HIV
- NCM-Plus
-
Westville, Durban, South Africa
- +14 more
Nov 16, 2021
Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic
Not yet recruiting
- Tuberculosis
- 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
- +5 more
-
Cairo, Kafr El-sheikh, Egypt
- +1 more
Oct 11, 2021